|
|
|
Based on a global supply shortage of the currently approved and marketed treatment for patients with Gaucher disease, and positive results from all
|
|
|
|
|
Vior has also obtained from the Ministere des Ressources naturelles et de la Faune du Quebec the authorization to complete a bulk sample on...
|
|
|
|
|
... announced that Swissmedic, the Swiss Agency for Therapeutic Products, has granted a marketing authorization for Amitiza® (lubiprostone) 24...
|
|
|
|
|
... has authorized a new $250 million stock repurchase authorization that will expire in three years. The new repurchase authorization allows the...
|
|
|
|
|
... announced that Swissmedic, the Swiss Agency for Therapeutic Products, has granted a marketing authorization for Amitiza® (lubiprostone) 24...
|
|
|
|
|
... has authorized a new $250 million stock repurchase authorization that will expire in three years. The new repurchase authorization allows the...
|
|
|
|
|
... today announced that Swissmedic, the Swiss Agency for Therapeutic Products, has granted a marketing authorization for Amitiza® This is...
|
|
|
|
|
... of fiscal 2009, the Company had authorization to purchase up to an additional $62.0 million of its common stock. This new authorization is in...
|
|
|
|
|
Toctino® has also received marketing authorization in Austria, Belgium, Finland, Luxemburg, the Netherlands, Spain and Switzerland.
|
|
|
|
|
Share Repurchase Authorization The Gymboree Corporation announced that its Board of Directors has authorized the Company to utilize up to $40...
|
|
